Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

EFPIA Urges Japan To Consider New Funding Models

Executive Summary

Amid intensifying official scrutiny of rising drug costs, the European industry federation EFPIA would like Japan to focus more on the measuring the actual benefits and health outcomes of new therapies, helped by new approaches and technology.

Advertisement

Related Content

Pricey New HCV, Cancer Drugs Push Up Japan’s Health Care Costs
EFPIA Highlights Europe ‘Lessons’ As Japan Ponders Policies
Drug Industry Urges Caution Over Japan HTA Plans

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register